Sylvie Bonvalot - Concepedia

Author

Sylvie Bonvalot

Also Known As

Bonvalot Sylvie, Bonvalot, S., Bonvalot, Sylvie, C. Chemin, Christophe Henry, Dan Blazer, E. Stoeckle, J Deroose, S Bielack, S Bonvalot

536

Publications

28.4K

Citations

H-Index

112

Concepts

All Affiliations

Institut Gustave Roussy Institut Curie Institut Bergonié Centre Léon Bérard Inserm

About

Sylvie Bonvalot is an author at Institut Gustave Roussy specializing in medicine, oncology, and surgical oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	51	95	12.4K
2	Health Sciences	12	14	1.4K
3	Biomedical Engineering	2	2	491
4	Engineering	1	1	22
5	Anatomy	1	1	31

Sylvie Bonvalot

165

Publications

24.6K

Citations

H-Index

Page 1

	Year	Citations
Pathologic assessment of tumor regression after preoperative chemoradiotherapy of esophageal carcinoma. Clinicopathologic correlations A.M. Mandard, Frédéric Dalibard, J.-C. Mandard, Cancer	1994	2K
Soft tissue and visceral sarcomas: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo G. Casali, N. Abecassis, Sebastian Bauer, Annals of Oncology	2018	1.6K
Soft tissue and visceral sarcomas: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up☆ Alessandro Gronchi, Aisha Miah, Angelo Paolo Dei Tos, Annals of Oncology Surgical OncologySoft Tissue SurgeryVisceral SarcomasSurgical PathologyHistopathology	2021	879
Gastrointestinal stromal tumours: ESMO–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo G. Casali, N. Abecassis, Sebastian Bauer, Annals of Oncology	2018	747
Primary Retroperitoneal Sarcomas: A Multivariate Analysis of Surgical Factors Associated With Local Control Sylvie Bonvalot, Michel Rivoire, Marine Castaing, Journal of Clinical Oncology	2008	630
Bone sarcomas: ESMO–PaedCan–EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo G. Casali, Stefan Bielack, N. Abecassis, Annals of Oncology	2018	618
Adjuvant chemotherapy with doxorubicin, ifosfamide, and lenograstim for resected soft-tissue sarcoma (EORTC 62931): a multicentre randomised controlled trial Penella J. Woll, Peter Reichardt, Axel Le Cesne, The Lancet Oncology Surgical OncologySoft-tissue SarcomaMedicineEortc 62931Metronomic Therapy	2012	572
Variability in Patterns of Recurrence After Resection of Primary Retroperitoneal Sarcoma (RPS) Alessandro Gronchi, Rosalba Miceli, Sylvie Bonvalot, Annals of Surgery	2016	529
Gastrointestinal stromal tumours: ESMO–EURACAN–GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up Paolo G. Casali, Jean‐Yves Blay, N. Abecassis, Annals of Oncology Surgical OncologyGastrointestinal OncologyMedicineSurgical PathologyGastroenterology	2021	509
NBTXR3, a first-in-class radioenhancer hafnium oxide nanoparticle, plus radiotherapy versus radiotherapy alone in patients with locally advanced soft-tissue sarcoma (Act.In.Sarc): a multicentre, phase 2–3, randomised, controlled trial Sylvie Bonvalot, Piotr Rutkowski, Juliette Thariat, The Lancet Oncology Radiation MedicineRadiation TherapyMedicineAdvanced Soft-tissue SarcomaRadiopharmaceutical Therapy	2019	469

Page 1